Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jordan

Showing results (1131-1140 of 1,202) with videos related to

Pageof 121
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, IndiaNitin K Hingankar, Smita R Thorat, Alaka Deshpande, et al.
British Journal of Cancer|October 4, 2017
Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targetsDaley S Morera, Martin S Hennig, Asif Talukder, et al.
Journal of Medicinal Chemistry|April 28, 2015
Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 5. A Novel Aryl Sulfone Series, Optimization Through Conformational AnalysisNuria A Tamayo, Mark H Norman, Michael D Bartberger, et al.
Molecular Cancer Research : MCR|August 13, 2024
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent MannerLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Medicine|September 14, 2020
High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in NamibiaMichael R Jordan, Ndapewa Hamunime, Leonard Bikinesi, et al.
Journal of Medicinal Chemistry|April 19, 2008
2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 miceLars Johansson, Christopher Fotsch, Michael D Bartberger, et al.
Scientific Reports|November 22, 2023
High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es SalaamGeorge M Bwire, Beatrice Godwin Aiko, Idda H Mosha, et al.
Science Translational Medicine|May 24, 2023
Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-GuérinFlorus C de Jong, Teemu D Laajala, Robert F Hoedemaeker, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2020
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 16, 2023
Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical TrialMichael A Pfeffer, Tia C L Kohs, Helen H Vu, et al.
Pageof 121

Showing results (1131-1140 of 1,202) with videos related to

Sort By:
Pageof 121
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 2012
Initial virologic response and HIV drug resistance among HIV-infected individuals initiating first-line antiretroviral therapy at 2 clinics in Chennai and Mumbai, IndiaNitin K Hingankar, Smita R Thorat, Alaka Deshpande, et al.
British Journal of Cancer|October 4, 2017
Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targetsDaley S Morera, Martin S Hennig, Asif Talukder, et al.
Journal of Medicinal Chemistry|April 28, 2015
Small Molecule Disruptors of the Glucokinase-Glucokinase Regulatory Protein Interaction: 5. A Novel Aryl Sulfone Series, Optimization Through Conformational AnalysisNuria A Tamayo, Mark H Norman, Michael D Bartberger, et al.
Molecular Cancer Research : MCR|August 13, 2024
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent MannerLily L Nguyen, Zachary L Watson, Raquel Ortega, et al.
Medicine|September 14, 2020
High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in NamibiaMichael R Jordan, Ndapewa Hamunime, Leonard Bikinesi, et al.
Journal of Medicinal Chemistry|April 19, 2008
2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 miceLars Johansson, Christopher Fotsch, Michael D Bartberger, et al.
Scientific Reports|November 22, 2023
High viral suppression and detection of dolutegravir-resistance associated mutations in treatment-experienced Tanzanian adults living with HIV-1 in Dar es SalaamGeorge M Bwire, Beatrice Godwin Aiko, Idda H Mosha, et al.
Science Translational Medicine|May 24, 2023
Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-GuérinFlorus C de Jong, Teemu D Laajala, Robert F Hoedemaeker, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2020
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 16, 2023
Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical TrialMichael A Pfeffer, Tia C L Kohs, Helen H Vu, et al.
Pageof 121